A Look at Recent Transactions Shaping the Future of Healthcare
This week's article provides a summary of recent healthcare M&A news for April 3, 2025.
The healthcare industry is rapidly evolving, with the lines between the healthcare technology and services sectors blurring - creating the catalyst for innovation, transformation, and continued market activity. TripleTree's Healthcare M&A Weekly summarizes recent mergers, acquisitions, and investments shaping the future of healthcare.
To view previous healthcare M&A activity, please review last week's post: Healthcare M&A Weekly - March 27, 2025.
-
Alcon, the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, a global medical technology company focused on advanced laser solutions for the treatment of cataracts, announced the companies have entered into a definitive merger agreement through which Alcon intends to acquire LENSAR. The transaction represents a total consideration of up to approximately $430M. Read more about the merger here. Alcon also announced it has acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Learn more about the acquisition here.
-
Ascend Learning, a healthcare and learning software company, acquired Clover Learning, a pioneer in online diagnostic imaging education. Click here for more on the acquisition.
-
Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, announced an oversubscribed $93M Series B financing round. The funding was co-led by new investors aMoon and Luma Group, with additional participation from Bausch + Lomb. Learn more about the financing here.
-
Epicrispr Biotechnologies, a biotechnology company focused on developing curative therapies, has secured $68M in the first close of its Series B financing. View the announcement here.
-
HOPE Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals, announced the signing of a binding Letter of Intent to acquire a majority interest in Neurospa, an operator of six interventional psychiatry clinics on Florida's Gulf Coast. Read the press release here.
-
Kardigan, a heart health company based in South San Francisco, acquired Prolaio, a Scottsdale, AZ-based clinical intelligence company advancing cardiology research. Click here for more on the acquisition.
-
Supira, a clinical-stage Shifamed portfolio company, announced the successful completion of an oversubscribed Series E financing round, raising $120M to accelerate the company's mission of transforming the percutaneous ventricular assist device (pVAD) market. The round was led by new investors Novo Holdings and Qatar Investment Authority, along with participation from two undisclosed strategic investors. Read more about the financing round here.
-
Tempero Bio, a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, announced the closing of a $70M Series B financing. The financing was led by 8VC with participation from Aditum Bio, Khosla Ventures, and other investors. View the announcement here.
-
VisiQuate, a Santa Rosa, CA-based leader in AI-powered revenue cycle management (RCM) backed by Accel-KKR, acquired Denver, CO-based Rotera, strengthening AI-driven automation in healthcare. Click here to learn more.
Transactions outlined in this summary highlight some of the key trends shaping the future of healthcare. Get the latest industry news from TripleTree every week.
This is a partial list of transaction activity across the healthcare industry and is not intended to be a complete listing. Transaction information was identified from various sources and TripleTree may or may not have acted as the financial advisor for the transactions listed. All product names, logos and brands are property of their respective owners. All company, product and service names used in this communication are for identification purposes only. Use of these names, logos and brands does not imply endorsement.
